The process underlying anaphylaxis involves an uncontrolled elevation in bl
ood levels of mediators, including histamine. Usually, these abnormal level
s are attributed to the degranulation of basophils and mast cells. Few repo
rts have assessed the contribution of defects in histamine pharmacodynamics
to allergic responses. In this report we describe a patient with recurrent
anaphylaxis who was initially suspected to have enhanced histamine intoler
ance. We evaluated urine and blood samples collected from this patient and
from control individuals using an ELISA test. Our data clearly show constit
utive hyperhistaminaemia and a markedly impaired urinary histamine clearanc
e ratio in the index patient. It is suggested that this defect facilitates
anaphylaxis.